Patent · US Active

Methods of administering 3,4-diaminopyridine

US11060128B2 · kind B2 · utility

5Cited by

7References

28Claims

0Family size

Assignee

SERB SA · BE

Inventors

Marvin R. Garovoy · Sausalito, US
Peter E. Haroldsen · Pacifica, US
Donald G. Musson · Larkspur, US

Key dates

Filing date	Sep 1, 2020
Grant date	Jul 13, 2021
Priority date	—
Expiry date	Sep 1, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.